Joyce McWhorter
Acute Care · Greer, SCNPI 1184260655
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,639 of the $7,144 with a category attached, or 78.9%. 24 manufacturers reported payments, led by AstraZeneca at 28.0% of the total. 2025 is the largest year on record at $2,926, 2.3 times the $1,264 reported in 2021. Among acute care clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $49.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Sanofi$2K
- Johnson & Johnson$364
- Regeneron Healthcare Solutions, Inc.$328
- Pulmonx Corporation$328
- Boehringer Ingelheim$328
- plus $2K from 18 others
What the payments were for
- Consulting fees$1,41020%
- Food & beverage$5,63979%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 39 | $2,001 |
| Sanofi | 21 | $1,910 |
| Johnson & Johnson | 4 | $364 |
| Regeneron Healthcare Solutions, Inc. | 9 | $328 |
| Pulmonx Corporation | 3 | $328 |
| Boehringer Ingelheim | 5 | $328 |
| Verona Pharma, Inc. | 20 | $277 |
| GSK | 9 | $230 |
| Inari Medical, Inc. | 1 | $199 |
| Insmed, Inc. | 4 | $156 |
| United Therapeutics Corporation | 3 | $133 |
| Merck | 6 | $124 |
| Grifols Shared Services North America, Inc. | 1 | $118 |
| Edwards Lifesciences | 2 | $115 |
| Teva Pharmaceuticals USA, Inc. | 1 | $110 |
| Amgen | 1 | $89 |
| Actelion Pharmaceuticals US, Inc. | 5 | $81 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $61 |
| BD | 1 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Viatris Specialty LLC | 2 | $39 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Lilly USA, LLC | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$455
- FASENRA$358
- XARELTO$350
- TEZSPIRE$346
- ZEPHYR ENDOBRONCHIAL VALVE$281
- FLOWTRIEVER CATHETER, S$199
- CT THROMBECTOMY SYSTEM KIT$199
- AIRSUPRA$133
- CHARTIS CATHETER$131
- ZEPHYR DELIVERY CATHETER$131
- PULMONX CHARTIS TABLET CONSOLE$131
- BREZTRI$122
- TRELEGY ELLIPTA$118
- Prolastin-C Liquid$118
- AirDuo RespiClick$110
- ArmonAir Digihaler$110
- ProAir Digihaler$110
- Arikayce$108
How this compares
$7,144 in reported general payments places this provider in the 90th percentile of 339 acute care providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 109 | $84,016 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 40 | $24,193 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 38 | $22,986 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $22,488 |
| Breo ElliptaFluticasone/Vilanterol | 49 | $21,966 |
| SymbicortBudesonide/Formoterol Fumarate | 72 | $21,932 |
| Spiriva RespimatTiotropium Bromide | 16 | $14,574 |
| Arnuity ElliptaFluticasone Furoate | 14 | $9,326 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 198 | $6,424 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 23 | $5,450 |
| Varenicline Tartrate | 11 | $2,270 |
| Wixela InhubFluticasone Propion/Salmeterol | 21 | $2,108 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,894 |
| Ventolin HfaAlbuterol Sulfate | 13 | $994 |
| Fluticasone Propionate | 69 | $895 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $230 | $139,500212 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,001 | $44,420101 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $328 | $37,56154 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 339 acute care providers in South Carolina.
Other acute care in Greer
- Heather BowersGreenville$94K
- Michael GajewskiColumbia$62K
- Heather NortonMt Pleasant$57K
- Cameron ThomassonSumter$28K
- Sarah MatthewsGreenville$28K
- Micheal BungerColumbia$15K
- Robin TrauflerColumbia$12K
- Susan FunkGreenville$11K
- Linda HentzLexington$10K
- Kylie CapdevilaFlorence$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.